Nobel Peace Prize Signals New Beginning For Pugwash

Sidebar: Plugging into Pugwash It would be reasonable to assume that last month's awarding of the Nobel Peace Prize to the Pugwash Conferences on Science and World Affairs and Pugwash president and cofounder Joseph Rotblat represents something of a glorious swan song. The conferences and Polish-born physicist Rotblat, 87, were honored by the Nobel Committee last month in Oslo, Norway, for their nearly 40-year effort "to diminish the part played by nuclear arms in international politics" (K.Y. K

Written byKaren Young Kreeger
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

It would be reasonable to assume that last month's awarding of the Nobel Peace Prize to the Pugwash Conferences on Science and World Affairs and Pugwash president and cofounder Joseph Rotblat represents something of a glorious swan song. The conferences and Polish-born physicist Rotblat, 87, were honored by the Nobel Committee last month in Oslo, Norway, for their nearly 40-year effort "to diminish the part played by nuclear arms in international politics" (K.Y. Kreeger, The Scientist, Nov. 13, 1995, page 1).

But as Rotblat and the group's many thousands of members and admirers point out emphatically, their work is hardly over. The challenges to peace and disarmament in the post-Cold War world are different-and in many ways more difficult-they maintain.

Although nuclear disarmament remains Pugwash's main concern, the subjects tackled at annual conferences and workshops have branched out in a number of directions. "The range of issues and topics has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies